These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 8709781)

  • 1. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease.
    Tang MX; Jacobs D; Stern Y; Marder K; Schofield P; Gurland B; Andrews H; Mayeux R
    Lancet; 1996 Aug; 348(9025):429-32. PubMed ID: 8709781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Profile of Alzheimer's disease in women].
    Villarroya-Pastor MT
    Rev Neurol; 2001 Jun 16-30; 32(12):1178-81. PubMed ID: 11562850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen replacement therapy in the elderly.
    Paganini-Hill A
    Zentralbl Gynakol; 1996; 118(5):255-61. PubMed ID: 8701621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oestrogen and Alzheimer's disease.
    Eaker ED
    Lancet; 1996 Oct; 348(9033):1028; author reply 1029-30. PubMed ID: 8855872
    [No Abstract]   [Full Text] [Related]  

  • 5. Onset of dementia is associated with age at menopause in women with Down's syndrome.
    Schupf N; Pang D; Patel BN; Silverman W; Schubert R; Lai F; Kline JK; Stern Y; Ferin M; Tycko B; Mayeux R
    Ann Neurol; 2003 Oct; 54(4):433-8. PubMed ID: 14520653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
    Brinton RD
    Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Estrogens and Alzheimer disease].
    Stähelin HB
    Schweiz Med Wochenschr; 1999 Dec; 129(49):1920-5. PubMed ID: 10635084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postmenopausal hormone therapy and Alzheimer's disease risk: interaction with age.
    Henderson VW; Benke KS; Green RC; Cupples LA; Farrer LA;
    J Neurol Neurosurg Psychiatry; 2005 Jan; 76(1):103-5. PubMed ID: 15608005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risks and benefits of estrogen replacement therapy: Leisure World.
    Paganini-Hill A
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 1():54-62. PubMed ID: 7581589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen-replacement therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging.
    Baldereschi M; Di Carlo A; Lepore V; Bracco L; Maggi S; Grigoletto F; Scarlato G; Amaducci L
    Neurology; 1998 Apr; 50(4):996-1002. PubMed ID: 9566385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen replacement therapy and risk of Alzheimer disease.
    Paganini-Hill A; Henderson VW
    Arch Intern Med; 1996 Oct; 156(19):2213-7. PubMed ID: 8885820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease, apolipoprotein E and hormone replacement therapy.
    Depypere H; Vierin A; Weyers S; Sieben A
    Maturitas; 2016 Dec; 94():98-105. PubMed ID: 27823753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailable estradiol and age at onset of Alzheimer's disease in postmenopausal women with Down syndrome.
    Schupf N; Winsten S; Patel B; Pang D; Ferin M; Zigman WB; Silverman W; Mayeux R
    Neurosci Lett; 2006 Oct; 406(3):298-302. PubMed ID: 16926067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT).
    Sourander L; Rajala T; Räihä I; Mäkinen J; Erkkola R; Helenius H
    Lancet; 1998 Dec 19-26; 352(9145):1965-9. PubMed ID: 9872245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein.
    Polvikoski T; Sulkava R; Haltia M; Kainulainen K; Vuorio A; Verkkoniemi A; Niinistö L; Halonen P; Kontula K
    N Engl J Med; 1995 Nov; 333(19):1242-7. PubMed ID: 7566000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease: an estrogen link?
    Beckmann CR
    Curr Opin Obstet Gynecol; 1997 Oct; 9(5):295-9. PubMed ID: 9360809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study.
    Ott A; Slooter AJ; Hofman A; van Harskamp F; Witteman JC; Van Broeckhoven C; van Duijn CM; Breteler MM
    Lancet; 1998 Jun; 351(9119):1840-3. PubMed ID: 9652667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease.
    in t' Veld BA; Ruitenberg A; Hofman A; Launer LJ; van Duijn CM; Stijnen T; Breteler MM; Stricker BH
    N Engl J Med; 2001 Nov; 345(21):1515-21. PubMed ID: 11794217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The apolipoprotein E epsilon 2 allele is associated with an increased risk of early-onset Alzheimer's disease and a reduced survival.
    van Duijn CM; de Knijff P; Wehnert A; De Voecht J; Bronzova JB; Havekes LM; Hofman A; Van Broeckhoven C
    Ann Neurol; 1995 May; 37(5):605-10. PubMed ID: 7755355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogens and hormone replacement therapy: is there a role in the preservation of cognitive function?
    Bieber EJ; Cohen DP
    Int J Fertil Womens Med; 2001; 46(4):206-9. PubMed ID: 11563830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.